Optical coherence tomography in ST-elevation myocardial infarction treated with novel drug-eluting stent: Preprocedural, postimplant and 2-month follow-up findings

Journal of Cardiovascular Medicine

Volumn 12, Issue 1, 2011, Pages 55-58

  Sirbu, Vasile ^a   Musumeci, Giuseppe ^a   Fiocca, Luigi ^a   Vassileva, Angelina ^a   Rossini, Roberta ^a   Lortkipanidze, Nikoloz ^a   Matiashvili, Aleksandre ^a   Mihalcsik, Laurian ^a   Gavazzi, Antonello ^a   Valsecchi, Orazio ^a   Guagliumi, Giulio ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Acute myocardial infarction; Optical coherence tomography; Trapidil eluting stent

Indexed keywords

CLOPIDOGREL; HIRULOG; TRAPIDIL;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CLINICAL EVALUATION; DRUG ELUTING STENT; FOLLOW UP; HEART VENTRICLE REMODELING; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; MORPHOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS; THROMBUS ASPIRATION;

CORONARY ANGIOGRAPHY; CORONARY VESSELS; DRUG-ELUTING STENTS; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSTHESIS IMPLANTATION; TOMOGRAPHY, OPTICAL COHERENCE; TRAPIDIL; TREATMENT OUTCOME;

EID: 79953728437     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283403409     Document Type: Article

References (11)

1. Kubo T, Imanishi T, Kashiwagi M, Ikejima H, Tsujioka H, Kuroi A, et al. Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. Am J Cardiol 2010; 105:318-322.
2. Gonzalo N, Serruys PW, Okamura T, Shen ZJ, Onuma Y, Garcia-Garcia HM, et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart 2009; 95:1913-1919.
3. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008; 118:1138-1145.
4. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluation by optical coherence tomography. Eur Heart J 2007; 28:961-967. (Pubitemid 47343895)
5. Otake H, Shite J, Ako J, Shinke T, Tanino Y, Ogasawara D, et al. Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. JACC Cardiovasc Interv 2009; 2:459-466.
6. Murata A, Wallace-Bradley D, Tellez A, Alviar C, Aboodi M, Sheehy A, et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging 2010; 3:76-84.
7. Khan M, Mhullá Nolan M. Intrepide: trapidil eluting stent. EuroIntervention 2008; 4:405-411.
8. Poon M, Cohen J, Siddiqui Z, Fulton JT, Taubman MB. Trapidil inhibits monocyte chemoattractant protein-1 (MCP-2) and macrophage accumulation after balloon arterial injury in rabbits. Lab Invest 1999; 79:1369-1375.
9. Zhou I, Ismaili J, Strodeur P, Thielemans K, Goldman M, Praider O. Inhibition of the CD40 pathway of monocyte activation by triazolopyrimidine (trapidil). Clin Immunol 1999; 93:232-238.
10. Elliot J, Maclssac A. On behalf of Destiny investigators. DESTINY 1 clinical trial: a first in man clinical evaluation of the ICON trapidil eluting coronary stent. Am J Cardiol 2005; 96(7A):210H.
11. Xie Y, Takano M, Murakami D, Yamamoto M, Okamatsu K, Inami S, et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am J Cardiol 2008; 102:27-31.